1,301 results on '"Ommen, Steve R."'
Search Results
102. PERSISTENCE OF LEFT ATRIAL THROMBUS AND RISK OF INCIDENT THROMBOEMBOLISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND ATRIAL FIBRILLATION
103. HYPERTROPHIC CARDIOMYOPATHY IS ASSOCIATED WITH HIGHER RISK OF LEFT ATRIAL THROMBUS IN PATIENTS WITH ATRIAL FIBRILLATION
104. Outcomes of Concomitant Myectomy and Left Ventricular Apical Aneurysm Repair in Patients with Hypertrophic Cardiomyopathy
105. Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy
106. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
107. Decreased Exercise Capacity and Sleep-Disordered Breathing in Patients With Hypertrophic Cardiomyopathy
108. Arrhythmias and Arrhythmia Management in Hypertrophic Cardiomyopathy
109. Hypertrophic Cardiomyopathy
110. Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
111. Composite Endpoints in Hypertrophic Cardiomyopathy
112. Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management
113. Development and implementation of a nurse-based remote patient monitoring program for ambulatory disease management
114. Impact of Incidental Amyloidosis on the Prognosis of Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction
115. Characterization of a Phenotype-Based Genetic Test Prediction Score for Unrelated Patients With Hypertrophic Cardiomyopathy
116. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
117. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?†
118. Arrhythmogenic Malignancies in Hypertrophic Cardiomyopathy
119. Outcome of Repair of Myocardial Bridging at the Time of Septal Myectomy
120. Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy
121. Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine
122. Transapical Approach to Myectomy for Midventricular Obstruction in Hypertrophic Cardiomyopathy
123. Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy
124. Outcome of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Children and Young Adults
125. Comparison of Surgical Septal Myectomy to Medical Therapy Alone in Patients With Hypertrophic Cardiomyopathy and Syncope
126. Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients With Hypertrophic Cardiomyopathy
127. Why we need more septal myectomy surgeons: An emerging recognition
128. Assessment of Left Ventricular Outflow Gradient: Hypertrophic Cardiomyopathy Versus Aortic Valvular Stenosis
129. Prognostic Utility of Metabolic Exercise Testing in Minimally Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
130. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: Results of operation in patients with latent obstruction
131. Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy
132. 54 - Hypertrophic Cardiomyopathy
133. Variability of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy
134. Apical Hypertrophic Cardiomyopathy: Prevalence and Correlates of Apical Outpouching
135. American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography
136. Hypertrophic Cardiomyopathy
137. Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy
138. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy
139. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
140. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
141. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: Summary of the literature and implications for genetic testing
142. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
143. Optimal Management of Mitral Regurgitation Due to Ruptured Mitral Chordae Tendineae in Patients With Hypertrophic Cardiomyopathy
144. Cardiopulmonary Exercise Test in Patients with Obstructive Hypertrophic Cardiomyopathy
145. Improvement in gastrointestinal bleeding after septal myectomy for hypertrophic cardiomyopathy
146. IN-HOSPITAL OUTCOMES OF ACUTE ISCHEMIC STROKE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
147. Additional file 1 of Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports
148. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI
149. Papillary Fibroelastomas in 19 Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy
150. Apical myectomy: A new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.